While there was a notable level of heterogeneity, it did not reach statistical significance ( I 2 = 97%, p = 0.04).
← all excerpts
Efficacy and Safety of PSCK9 Inhibitors on Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
1
0.0400
0.0400